Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-12

Clinical Trial Update: Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating combined Restylane and Triamcinolone Acetonide injections for alopecia areata; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Restylane (hyaluronic acid dermal filler)
  • TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: University of Minnesota | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2021-01-12